Millennium Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Millennium Management’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,585	Closed	-$324K	–	3451
2015 Q2	$324K	Sell	3,585 -3,993	-53%	-$344K	﹤0.01%	2851
2015 Q1	$600K	Buy	7,578 +852	+13%	+$63.2K	﹤0.01%	2647
2014 Q4	$422K	Buy	+6,726	New	+$395K	﹤0.01%	3110
2014 Q2	–	Sell	-11,740	Closed	-$469K	–	3404
2014 Q1	$469K	Buy	+11,740	New	+$533K	﹤0.01%	2656

Other funds holding BIB

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VCAM

Valentine Capital Asset Management Danville, California $89.6M AUM 0.84% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

WSTAM

Wilbanks Smith & Thomas Asset Management Norfolk, Virginia $3.57B AUM 21.11% 1-Year Est. Return

BHA

Beech Hill Advisors New York $200M AUM 25.74% 1-Year Est. Return

Millennium Management's BIB Position: Q3 2015 in Review

Millennium Management sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2015, closing a stake of 3,585 shares — an estimated $324K sold.

Millennium Management first reported a position in BIB in Q1 2014 and held it in 4 quarters. The position peaked at $600K in Q1 2015. 24 funds tracked by Wall St. Rank hold BIB as of Q3 2015.

Millennium Management reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2015 after selling out during the quarter.
Millennium Management sold 3,585 ProShares Ultra NASDAQ Biotechnology shares in Q3 2015, an estimated $324K.
Millennium Management first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2014 and held it in 4 quarters.
Millennium Management's ProShares Ultra NASDAQ Biotechnology position peaked at $600K in Q1 2015.
24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2015.

Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.